Annual report pursuant to Section 13 and 15(d)

SHAREHOLDERS' EQUITY - Stock Options (Details)

v3.23.1
SHAREHOLDERS' EQUITY - Stock Options (Details) - $ / shares
 1 Months Ended 12 Months Ended
Nov. 15, 2021
Jun. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share Capital          
Shares issued 909,262 7,802      
Stock options          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]          
Options at beginning of period (in shares)     60,212 37,430  
Options granted (in shares)     6,500 27,250  
Options exercised (in shares)     (40) (150)  
Options canceled / expired (in shares)     (17,632) (4,318)  
Options at end of period (in shares)     49,040 60,212 37,430
Options vested and exercisable as at end of the period     34,163    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]          
Exercise Price at beginning of period (in dollars per share)     $ 111.20 $ 105.00  
Options granted (in dollars per share)     103.20 123.40  
Options exercised (in dollars per share)     100.80 128.00  
Options canceled / expired (in dollars per share)     50.20 119.80  
Exercise Price at end of period (in dollars per share)     129.60 $ 111.20 $ 105.00
Exercise Price vested and exercisable (in dollars per share)     $ 135.20    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]          
Weighted Average Remaining Contractual Life (in years)     2 years 9 months 18 days 3 years 7 months 6 days 4 years
Weighted Average Remaining life vested and exercisable (in years)     2 years 4 months 24 days    
Stock options | Consultants          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]          
Options granted (in shares)     0 0